Texas Attorney General Sues Acetaminophen Makers Over Autism Allegations

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the companies concealed potential risks that the pain reliever presented to pediatric cognitive development.

The lawsuit arrives four weeks after Donald Trump publicized an unproven link between taking Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in offspring.

Paxton is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from discomfort and pushing pills ignoring the risks."

The manufacturer states there is insufficient reliable data connecting acetaminophen to autism spectrum disorder.

"These companies misled for generations, intentionally threatening numerous people to increase profits," the attorney general, from the Republican party, declared.

The manufacturer stated officially that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the welfare of US mothers and children."

On its official site, the company also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a established connection between taking acetaminophen and autism."

Groups speaking for medical professionals and healthcare providers agree.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is a restricted selection for expectant mothers to address pain and fever, which can create significant medical dangers if ignored.

"In more than two decades of research on the consumption of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the consumption of paracetamol in any trimester of gestation causes brain development issues in young ones," the association commented.

This legal action mentions latest statements from the previous government in claiming the drug is potentially dangerous.

In recent weeks, Trump generated worry from medical authorities when he advised expectant mothers to "struggle intensely" not to use Tylenol when sick.

Federal regulators then published an announcement that medical professionals should contemplate reducing the use of Tylenol, while also mentioning that "a direct connection" between the drug and autism in children has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had pledged in spring to conduct "comprehensive study program" that would determine the source of autism in a matter of months.

But experts warned that finding a single cause of autism - believed by scientists to be the consequence of a intricate combination of genetic and environmental factors - would not be simple.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how people encounter and relate to the world, and is recognized using doctors' observations.

In his legal document, the attorney general - who supports Trump who is seeking US Senate - asserts the manufacturer and J&J "intentionally overlooked and attempted to silence the research" around paracetamol and autism spectrum disorder.

This legal action aims to force the corporations "eliminate any marketing or advertising" that asserts acetaminophen is secure for expectant mothers.

This legal action parallels the concerns of a collection of guardians of young ones with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in two years ago.

Judicial authorities threw out the legal action, declaring studies from the parents' expert witnesses was not conclusive.